Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Aurinia Pharmaceuticals Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 198 | 3 | 191 | −4 |
| Shares | 50.9M | 1.12M | 54.0M | +4.26M (+8.6%) |
| Value | $395.2M | $8.67M | $485.4M | +$98.9M (+25.6%) |
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schroder Investment Management Group | 1,040,530 | $9.35M | 0.01% |
| Marex Group plc | 355,000 | $3.19M | 0.13% |
| Campbell & CO Investment Adviser LLC | 232,411 | $2.09M | 0.19% |
| 683 Capital Management, LLC | 220,000 | $1.98M | 0.20% |
| Gsa Capital Partners LLP | 117,944 | $1.06M | 0.09% |
| Cubist Systematic Strategies, LLC | 88,622 | $796.7K | 0.01% |
| Privium Fund Management (UK) Ltd | 67,853 | $593.0K | 0.40% |
| Sierra Summit Advisors LLC | 22,436 | $201.7K | 0.06% |
| GTS Securities LLC | 17,350 | $156.0K | 0.00% |
| Creative Planning | 11,384 | $102.3K | 0.00% |
| Eagle Asset Management Inc | 10,210 | $91.8K | 0.00% |
| EntryPoint Capital, LLC | 5,163 | $46.4K | 0.04% |
| Tidemark, LLC | 4,340 | $39.0K | 0.02% |
| Vermillion & White Wealth Management Group, LLC | 3,300 | $29.7K | 0.03% |
| GAMMA Investing LLC | 778 | $5.87K | 0.00% |
| Frazier Financial Advisors, LLC | 500 | $4.50K | 0.00% |
| CVA Family Office, LLC | 139 | $1.25K | 0.00% |
| Farther Finance Advisors, LLC | 57 | $512 | 0.00% |
| Vima LLC | 25 | $225 | 0.00% |
| Parallel Advisors, LLC | 12 | $108 | 0.00% |
| The PNC Financial Services Group, Inc. | 8 | $72 | 0.00% |
| Ronald Blue Trust, Inc. | 55 | $0 | 0.00% |
Sold out (26)
Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
Not filed for Q4 2023 yet (3)
Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 1,040,530 | $8.07M |
| Virginia Retirement Systems Et Al | 76,200 | $592.1K |
| Steward Financial Group LLC | 1,000 | $7.00K |